Becker's Healthcare June 27, 2024
An inhalable drug treatment for chronic obstructive pulmonary disease received FDA-approval June 26, drugmaker Verona Pharma announced.
It is the first FDA-approved treatment for COPD in more than two decades, according to the release.
“[D]espite maintenance therapy, most patients report grappling with daily symptoms, including breathlessness and persistent coughing,” Michael Wells, MD, associate professor in the division of pulmonary, allergy, and critical care medicine at the University of Alabama Birmingham,...
Today's Sponsors
Today's Sponsor